Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marisa Iborra

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Gut and Liver|January 19, 2017
Decreased Esophageal Sensitivity to Acid in Morbidly Obese Patients: A Cause for Concern?Vicente Ortiz, Diego Alvarez-Sotomayor, Esteban Sáez-González, et al.
Inflammatory Bowel Diseases|March 30, 2019
A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease RecurrenceElena Cerrillo, Inés Moret, Marisa Iborra, et al.
Gastroenterologia Y Hepatologia|July 4, 2012
[Peripheral arterial thromboembolism in Crohn's disease]Isabel Ferrer, Guillem Benavent, Guillermo Bastida, et al.
Digestive Diseases (Basel, Switzerland)|April 24, 2020
Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log DropBeatriz Mateos, Esteban Sáez-González, Inés Moret, et al.
Journal of Crohn'S & Colitis|April 24, 2024
Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJohn David Chetwood, Yvonne Tran, Sreedhar Subramanian, et al.
Digestive Diseases and Sciences|April 23, 2017
Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel DiseaseEsteban Sáez-González, Inés Moret, Diego Alvarez-Sotomayor, et al.
Scandinavian Journal of Gastroenterology|September 7, 2018
Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?Jose M Huguet, Marisa Iborra, Marta Maia Bosca-Watts, et al.
Inflammatory Bowel Diseases|July 29, 2009
Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's diseaseBelén Beltrán, Pilar Nos, Francisco Dasí, et al.
World Journal of Gastroenterology|September 13, 2012
Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patientsMariam Aguas, Guillermo Bastida, Elena Cerrillo, et al.
Biomedicines|November 27, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational StudyAlejandro Mínguez, Beatriz Mateos, Marisa Iborra, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Gut and Liver|January 19, 2017
Decreased Esophageal Sensitivity to Acid in Morbidly Obese Patients: A Cause for Concern?Vicente Ortiz, Diego Alvarez-Sotomayor, Esteban Sáez-González, et al.
Inflammatory Bowel Diseases|March 30, 2019
A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease RecurrenceElena Cerrillo, Inés Moret, Marisa Iborra, et al.
Gastroenterologia Y Hepatologia|July 4, 2012
[Peripheral arterial thromboembolism in Crohn's disease]Isabel Ferrer, Guillem Benavent, Guillermo Bastida, et al.
Digestive Diseases (Basel, Switzerland)|April 24, 2020
Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log DropBeatriz Mateos, Esteban Sáez-González, Inés Moret, et al.
Journal of Crohn'S & Colitis|April 24, 2024
Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysisJohn David Chetwood, Yvonne Tran, Sreedhar Subramanian, et al.
Digestive Diseases and Sciences|April 23, 2017
Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel DiseaseEsteban Sáez-González, Inés Moret, Diego Alvarez-Sotomayor, et al.
Scandinavian Journal of Gastroenterology|September 7, 2018
Inflammatory bowel disease in patients over the age of 70 y. Does the disease duration influence its behavior?Jose M Huguet, Marisa Iborra, Marta Maia Bosca-Watts, et al.
Inflammatory Bowel Diseases|July 29, 2009
Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's diseaseBelén Beltrán, Pilar Nos, Francisco Dasí, et al.
World Journal of Gastroenterology|September 13, 2012
Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patientsMariam Aguas, Guillermo Bastida, Elena Cerrillo, et al.
Biomedicines|November 27, 2025
Cytokine Dynamics During Ustekinumab Induction as Predictors of Treatment Response in Crohn's Disease: An Observational StudyAlejandro Mínguez, Beatriz Mateos, Marisa Iborra, et al.
Pageof 10